Abstract-Multi-modality imaging has an increasing role in the diagnosis and treatment of a large number of diseases, particularly if both functional and anatomical information are acquired and accurately co-registered. Although PET-CT has recently revolutionized the role of imaging for many kinds of cancer, ultrasound is the preferred imaging technology for many diseases such as prostate cancer. Transrectal ultrasound (TRUS) is an integral part of diagnosis and treatment for prostate cancer, so we are developing a dual imaging system that will acquire PET and TRUS data during the same patient imaging session and accurately co-register the images. In order to validate our methods prior to patient imaging, we will use a novel custom PET-TRUS prostate phantom. We present our initial PETultrasound phantom development, including PET and ultrasound images of a simple phantom, as well as discuss of our future phantom construction plans. We will use agar-gelatin tissue mimicking materials mixed with radioactive water solutions. Although we are currently focused on prostate imaging, this phantom development is applicable to all PET-ultrasound imaging applications. In addition, we discuss how to make a PET-ultrasound phantom also MRI and/or CT compatible.
I. INTRODUCTION
ulti-modality imaging plays an increasingly important role in the diagnosis and treatment of a large number of diseases. Combining modalities that provide both functional and structural information is particularly important. For instance, functional information can be acquired with positron emission tomography (PET) or functional magnetic resonance imaging (fMRI), and anatomical information can be acquired using x-ray computed tomography (CT), ultrasound (US) or magnetic resonance imaging (MRI). Combining PET and CT has recently revolutionized the role of imaging in diagnosis and treatment planning for many kinds of cancer. However, ultrasound is already an integral part of diagnosis and treatment procedures for many diseases, such as prostate cancer. Transrectal ultrasound (TRUS) provides good anatomical detail of the prostate region and accurately measures the prostate volume, whereas CT has poor contrast for soft-tissue (like the prostate) and it over-estimates prostate volume.
We believe that imaging the prostate with 11 C-choline using a dual PET-TRUS system will help locate cancer within the prostate region. We envision that dual PET-TRUS prostate imaging could be used to guide biopsy, guide treatment procedures such as external beam radiotherapy and brachytherapy, and detect local recurrence earlier than current clinical practice. Therefore, we are developing a dual imaging system that acquires PET and TRUS data sets during the same patient imaging session using methods that allow us to accurately determine the 3D location of the TRUS probe tip (relative to the PET scanner). As a result, co-registration of the PET and TRUS patient images will be simple and accurate. However, prior to our patient studies, we must validate our ability to image and accurately co-register PET and TRUS images using a PET-TRUS prostate phantom. We will build a custom PET-TRUS prostate phantom with structures that simulate the acoustical properties for TRUS and 511 keV activity concentrations for PET.
We present here our initial PET-ultrasound phantom and PET-US-CT-MRI phantom development, including multimodality images of simple phantoms. This phantom development is applicable to many multi-modality applications. We will also discuss our future prostate phantom construction plans.
II. CUSTOM PET-ULTRASOUND PHANTOM
We have constructed a simple PET-ultrasound prostate phantom as proof of principle. When developing the procedures for our phantom construction, we used short-lived 18 F radioactive (110 minutes half-life) water solutions, since 18 F is readily available from our in-house cyclotron and no long-lived radioactive waste were generated by the tests. Our simple PET-US phantom was constructed in two stages. We first filled a rectangular plastic box with 4% agarose that was prepared as a high-scatter ultrasound tissue mimicking material (TMM), creating a void with a petrolatum-coated plastic rod in the center. Once the rectangular agarose "pelvis" hardened, the rod was removed and we filled the inner cylindrical "prostate" region with a low-scatter ultrasound 8% gelatin TMM. Fig. 1a shows a photograph of the PET-US phantom. At each stage, the TMM was mixed with 18 F radioactive water solution before putting it into a refrigerator to harden. The phantom had six times higher 511 keV activity density in the inner cylindrical "prostate" than in the outer rectangular "pelvis."
The phantom was roughly centered in an EXACT HR PET camera, and PET data were acquired with a 10 minute transmission scan followed by a 20 minute emission scan in 3D mode. At the start of the emission scan, the 18 F activity density was 1.07 μCi/ml in the cylindrical "pelvis" gelatin and 0.17 μCi/ml in the rectangular "pelvis" agarose. Image reconstruction was performed with attenuation and scatter correction. Reconstructed coronal PET image of the PET-ultrasound phantom. The redyellow circle shows the high 18 F activity concentration in the "prostate" region, and the blue rectangle shows the low 18 F activity concentration in the background "pelvis" region. Image represents 636 M counts (i.e., 20 minutes of data). The voxel size is 1.47 mm x 1.47 mm x 3.13 mm. (c) Ultrasound image of the same phantom using a 5MHz external ultrasound probe. The dark gray circle shows the low-scatter gelatin "prostate," and the surrounding light gray background shows the high-scatter agarose "pelvis."
The phantom was then imaged using a 5 MHz external Elektra ultrasound system, as shown in Fig. 1c . The ultrasound image clearly shows the low-scatter cylindrical "prostate" gelatin, which is surrounded by the high-scatter "pelvis" agarose. Thus, we have demonstrated our ability to construct and image a custom PET-ultrasound phantom. However, the phantom's mechanical and ultrasound properties did not have long-term stability especially at room temperature.
III. CUSTOM PET-US-CT-MRI PHANTOM
Methods on ultrasound phantom construction are well represented in literature [1] [2] [3] [4] [5] . Since the phantom described in section II did not have long-term stability at room temperature, we needed to develop a different phantom construction process. We have constructed a multi-modality phantom using tissue mimicking mixtures of agar, gelatin, CuCl 2 -2H 2 O, EDTA-tetra Na Hydrate, NaCl, HCHO, Germall-Plus TM , glass beads, BaSO 4 , and deionized water ( Table I) . Similar agar-gelatin mixtures were proven to have long-term mechanical, ultrasound and MRI properties for at least one year [ 5] . These agar-gelatin-based tissue mimicking materials can be mixed with radioactive water solutions. When developing the procedures for the agar-gelatin-based phantom construction, we used non-radioactive water and short-lived 18 F radioactive water solutions. Once the phantom construction procedures are finalized, we will use long-lived 68 Ge radioactivity (271 day half-life) for phantom construction to allow repeated PET imaging of the same phantom over at least one year. The main purpose of this phantom is to develop radioactive TMMs, with long-term stability at room temperature, that approximate the acoustical properties of patients more accurately than those developed in section II.
We constructed a two-region PET-US-CT-MRI phantom with an inner cylindrical "prostate" within an outer rectangular "pelvis" (i.e., with the same simple geometry as the PET-US phantom described in section II). We first filled the rectangular "pelvis" container with the "Pelvis TMM" (Table  I) , creating a void with a petrolatum-coated plastic rod in the center. This rod was removed once the rectangular "pelvis" hardened, then we filled the inner cylindrical "prostate" with a "Prostate TMM" (Table I) having different multi-modality properties and 18 F activity. The TMMs were hardened at room temperature. Fig. 2 shows a photograph of the custom PET-US-CT-MRI phantom. Table I . Dry-weight percents of the various components in the PET-US-CT-MRI custom phantom. The weight percent of the deionized water is not shown since it makes up the remainder. Table I outlines the dry-weight percents for the "Prostate TMM" and "Pelvis TMM" used to construct the custom PET-US-CT-MRI phantom. For these tests, only the cylindrical "prostate" TMM was mixed with a 18 F-water solution. The primary role of each ingredient is summarized below:
• Agar: concentration set to achieve tissue-like US properties, such as US propagation speed. Higher agar concentration also produces shorter longitudinal (T 1 ) and transverse (T 2 ) MRI relaxation times.
• Gelatin: concentration set for tissue-like US properties, such as US propagation speed. Concentration must be roughly the same for "prostate" and "pelvis" regions to avoid changes in volumes due to osmosis.
• CuCl 2 -2H 2 O and EDTA-tetra Na Hydrate: EDTA forms chelate with the Cu 2+ ions to allow Cu 2+ to remain mobile, allowing controlled lowering of the T 1 MRI relaxation time.
• NaCl: anti-bacterial agent that produces tissue-like MRI coil loading.
• HCHO (37% formaldehyde): cross-links the gelatin, raising the melting point to 78 °C where the agar component melts.
• Germall-Plus TM : preservative to prevent fungal and bacterial invasion.
• Glass Beads (20 μm average diameter): increases ultrasound attenuation and backscatter to tissue-like levels. Also lowers T 1 and T 2 MRI relaxation times.
• BaSO 4 : increases radiographic attenuation for CT.
• 18 F: 511 keV radioactivity for PET imaging.
The expected ultrasound properties include a propagation speed of about 1535 m/s, a density of about 1.04 g/ml, and an attenuation coefficient divided by frequency of about 0.14 dB/cm/MHz for the "Prostate TMM" and 0.38 dB/cm/MHz for the "Pelvis TMM." The MRI T 1 relaxation times are expected to be about 494 ms for the "Prostate TMM" and 423 ms for the "Pelvis TMM" [5] . Fig. 2 . Photograph of a custom PET-US-CT-MRI phantom. The aquacolored rectangular "pelvis" has outer dimensions of 16 cm x 11 cm x 3.5 cm. The dark green-colored cylindrical "prostate" has a 5 cm diameter and 2.5 cm depth (i.e. inner cylinder does not go all the way through).
The custom PET-US-CT-MRI phantom was imaged using an EXACT HR PET scanner. PET data were acquired with a 3D emission scan followed by a 10 minute transmission scan. Iterative image reconstruction was performed with attenuation and scatter correction. Fig. 3a shows a reconstructed coronal PET image of the phantom. The 18 F activity concentrated in the cylindrical "prostate" is clearly visible. The PET image in the "prostate" region is not uniform in this case (e.g., compared to Fig. 1b) due to PET scanner hardware problems that affected the attenuation map and normalization.
(a) (b) (c) Fig. 3. (a) Reconstructed coronal PET image of the custom PET-US-CT-MRI phantom. The colored circle shows the 18 F activity in the "prostate" region; the 18 F activity density was 0.8 μCi/ml in the "prostate" at the start of the 60 minute emission scan. Voxel size is 3.6 mm x 3.6 mm x 4 mm. (b) Ultrasound image of the phantom using a 5 MHz external ultrasound probe. The dark gray circle shows the lower-scatter "prostate," and the surrounding gray background shows the higher-scatter "pelvis." (c) Reconstructed coronal x-ray CT image of the phantom with 1 cm axial thick slices. The pixel size is 1 mm x 1 mm x 10 mm. The dark gray circle shows lower radiographic attenuation in the "prostate" compared with the surrounding light gray higherattenuation "pelvis."
The custom PET-US-CT-MRI phantom was imaged by the other three modalities the following day, after the 18 F radioactivity decayed. The phantom was imaged with a 5MHz external Elektra ultrasound system. Fig. 3b shows an ultrasound image of the phantom with a lower-scatter cylindrical "prostate" surrounded by higher-scatter "pelvis." The phantom was then imaged with a Hawkeye CT scanner (140 keV; 2.5 mAmps) on a Millennium VG3 SPECT gantry. Reconstruction was performed with filtered backprojection using a Hann filter with a cutoff frequency of 1. Fig. 3c shows a reconstructed coronal CT image of the phantom with increased radiographic attenuation in the "pelvis" due to the BaSO 4 .
Finally, the phantom was imaged with an 1.5 T Avanto Siemens MRI scanner using a head coil with a T 1 -weighted 2D spin echo pulse sequence (TE = 7.8 msec; TR = 500 msec; field of view = 220 mm x 178.8 mm x 3 mm; voxel size = 0.4 mm x 0.4 mm x 3 mm). Fig. 4a shows a reconstructed T 1 -weighted MRI image with a darker "prostate" representing a longer T 1 compared to the "pelvis." The glass beads (used for ultrasound imaging) shortened the T 1 in the "pelvis" to make it brighter, despite the increased agar concentration in the "prostate." The phantom was also imaged with a T 2 -weighted 2D turbo spin echo pulse sequence (TE = 91 msec; TR = 4000 msec; field of view = 220 mm x 175.3 mm x 3 mm; voxel size = 0.4 mm x 0.4 mm x 3 mm). Fig. 4b shows a reconstructed T 2 -weighted MRI image with a darker "prostate" representing a shorter T 2 compared to the "pelvis." 
IV. FUTURE PLANS
We plan to make a PET-TRUS prostate phantom with a more realistic geometry using 68 Ge water in a finalized agargelatin mixture (as determined from above). The phantom will have structures simulating the prostate, rectal wall and urethra in a background gel with an opening for the TRUS probe (Fig.  5) . The urethra is routinely simulated by filling a tube with ultrasound gel with some air bubbles. We will image this PET-TRUS prostate phantom with PET and TRUS to confirm that we have produced a phantom with the required properties. Since this PET-TRUS prostate phantom will be used only to validate image co-registration, the phantom does not have to exactly mimic the PET and TRUS properties of the prostate region. If the agar-gelatin mixture does not work, other tissue mimicking materials could be used. Typical TMMs include agar, Zerdine TM , urethanes, epoxies, liquids and natural materials. There are three TMMs commercially available: Zerdine TM from CIRs Inc., condensed-milk-based gel from Gammax RMI, and urethane-rubber-based material from ATS Labs. If necessary, we could investigate alternative phantom construction using radioactive water in condensed milk-agarbased mixtures [2] or poly(vinyl alcohol) cryogels [4] .
V. CONCLUSIONS
We have successfully developed multi-modality phantoms, including a PET-US-CT-MRI phantom with two regions distinguishable by all four imaging modalities and long-term stability expected at room temperature. These phantoms had a relatively simple geometry, as their main purpose was to develop phantom construction methods. Our final multimodality prostate phantom will be used to validate image coregistration for PET and TRUS prostate imaging. This prostate phantom will have a more realistic geometry (e.g., rectal probe opening), but it does not have to exactly mimic the TRUS tissue properties or anatomy of the prostate region. Long-lived 68 Ge will be used for the final prostate phantom, to allow repeated use over at least a year.
